Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TSHA Taysha Gene Therapies, Inc.

盘前交易 12-05 06:17:34 EST

5.06

+0.57

+12.69%

最高5.10	最低4.65	成交量562.44万
今开4.82	昨收4.49	日振幅10.02%
总市值13.86亿	流通市值9.31亿	总股本2.74亿
成交额2,779万	换手率3.06%	流通股本1.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TSHA","market":"US","secType":"STK","nameCN":"Taysha Gene Therapies, Inc.","latestPrice":5.06,"timestamp":1764882000000,"preClose":4.49,"halted":0,"volume":5624448,"delay":0,"floatShares":184000000,"shares":273919373,"eps":-0.335921,"marketStatus":"盘前交易","change":0.57,"latestTime":"12-05 06:17:34 EST","open":4.82,"high":5.095,"low":4.645,"amount":27791415.593088,"amplitude":0.100223,"askPrice":5.06,"askSize":200,"bidPrice":4.96,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.335921,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1764945000000},"marketStatusCode":1,"adr":0,"listingDate":1600920000000,"exchange":"NASDAQ","adjPreClose":5.06,"postHourTrading":{"tag":"盘后","latestPrice":5.08,"preClose":5.06,"latestTime":"19:46 EST","volume":26062,"amount":132584.2489,"timestamp":1764895590192},"volumeRatio":2.3189537765693315,"impliedVol":0.8792,"impliedVolPercentile":0.4257},"requestUrl":"/m/hq/s/TSHA","defaultTab":"news","newsList":[{"id":"2583562799","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大涨5.02%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583562799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583562799?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:34","pubTimestamp":1762961640,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日23时34分，Taysha Gene Therapies, Inc.股票出现波动，股价急速上涨5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223340095003041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223340095003041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2579151013","title":"Taysha Gene Therapies, Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579151013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579151013?lang=zh_cn&edition=full","pubTime":"2025-10-30 02:00","pubTimestamp":1761760810,"startTime":"0","endTime":"0","summary":"北京时间2025年10月30日02时00分，Taysha Gene Therapies, Inc.股票出现异动，股价快速上涨5.01%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Wave Life Sciences Ltd.涨幅较大，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Aditxt, Inc.较为活跃，换手率分别为4096.17%、2547.31%、419.04%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Purple Biotech Ltd、Ernexa Therapeutics Inc.，振幅分别为139.33%、93.83%、91.19%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103002001094e41968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103002001094e41968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"1180796576","title":"Taysha Gene Therapies Inc：Raymond James 给予强烈买入评级，目标价 $13","url":"https://stock-news.laohu8.com/highlight/detail?id=1180796576","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180796576?lang=zh_cn&edition=full","pubTime":"2025-10-21 19:36","pubTimestamp":1761046571,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies Inc：Raymond James 给予强烈买入评级，目标价 $13","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"1100118926","title":"Taysha Gene Therapies重新获得全权领导Tsha-102项目，用于雷特综合症的临床评估","url":"https://stock-news.laohu8.com/highlight/detail?id=1100118926","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100118926?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:02","pubTimestamp":1760644931,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies重新获得全权领导Tsha-102项目，用于雷特综合症的临床评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2572263491","title":"Taysha Gene Therapies, Inc.盘中异动 快速上涨5.33%报5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572263491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572263491?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:31","pubTimestamp":1759498294,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时31分，Taysha Gene Therapies, Inc.股票出现波动，股价大幅拉升5.33%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Ovid Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Ovid Therapeutics Inc.、Palisade Bio, Inc.、Alto Neuroscience, Inc.较为活跃，换手率分别为42.42%、25.79%、13.61%，振幅较大的相关个股有Palisade Bio, Inc.、Shattuck Labs, Inc.、Enveric Biosciences, Inc.，振幅分别为14.71%、7.96%、7.72%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213135971e772a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213135971e772a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2560920824","title":"Taysha Gene Therapies, Inc.2025财年第二财季实现净利润-26.88百万美元，同比减少28.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560920824","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560920824?lang=zh_cn&edition=full","pubTime":"2025-08-18 00:02","pubTimestamp":1755446524,"startTime":"0","endTime":"0","summary":"8月18日，Taysha Gene Therapies, Inc.公布财报，公告显示公司2025财年第二财季净利润为-26.88百万美元，同比减少28.43%；其中营业收入为1.99百万美元，同比增加79.28%，每股基本收益为-0.09美元。从资产负债表来看，Taysha Gene Therapies, Inc.总负债84.60百万美元，其中短期债务2.15百万美元，资产负债比为0.04，流动比率为0.13。机构评级：截至2025年8月18日，当前有12家机构对Taysha Gene Therapies, Inc.目标价做出预测，其中目标均价为8.67美元，其中最低目标价为5.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000439a48deca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000439a48deca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA"],"gpt_icon":0},{"id":"1198284348","title":"异动解读 | 泰沙基因治疗公司发布季度财报后股价盘中大涨7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198284348","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198284348?lang=zh_cn&edition=full","pubTime":"2025-08-12 22:04","pubTimestamp":1755007458,"startTime":"0","endTime":"0","summary":"泰沙基因治疗公司今日盘中大涨7.25%，引起投资者广泛关注。该公司刚刚公布了截至6月30日的季度财报，虽然每股收益略低于预期，但收入增长强劲，超出市场预期。根据公司发布的财报，泰沙基因治疗公司第二季度调整后每股亏损9美分，与去年同期持平，略低于分析师平均预期的8美分亏损。尽管季度业绩喜忧参半，但华尔街分析师对泰沙基因治疗公司保持乐观态度。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TSHA"],"gpt_icon":0},{"id":"2555028899","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555028899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555028899?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:16","pubTimestamp":1753885000,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时16分，Taysha Gene Therapies, Inc.股票出现异动，股价大幅拉升5.34%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302216409727f295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302216409727f295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2551933001","title":"Taysha Gene Therapies, Inc.盘中异动 早盘急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551933001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551933001?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:28","pubTimestamp":1752589693,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时28分，Taysha Gene Therapies, Inc.股票出现波动，股价急速跳水5.11%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Polyrizon Ltd.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Polyrizon Ltd.、Kairos Pharma, Ltd.较为活跃，换手率分别为1493.04%、1352.92%、1024.90%，振幅较大的相关个股有Kairos Pharma, Ltd.、Polyrizon Ltd.、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为109.47%、75.50%、66.39%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152228139543968c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152228139543968c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2550952740","title":"Taysha Gene Therapies, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550952740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550952740?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:59","pubTimestamp":1752245956,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时59分，Taysha Gene Therapies, Inc.股票出现波动，股价急速拉升5.10%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。其相关个股中，Mink Therapeutics, Inc.、Cel-Sci Corporation、Calcimedica, Inc.涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为500.58%、214.91%、82.76%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为495.47%、74.61%、35.73%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711225916a4452178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711225916a4452178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2550229725","title":"Taysha Gene Therapies, Inc.盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550229725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550229725?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:18","pubTimestamp":1751995125,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时18分，Taysha Gene Therapies, Inc.股票出现波动，股价急速上涨5.13%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709011846a43e7cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709011846a43e7cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2548886941","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886941?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:13","pubTimestamp":1751386412,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时13分，Taysha Gene Therapies, Inc.股票出现异动，股价急速上涨5.19%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020013329532c30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020013329532c30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2546575342","title":"Taysha Gene Therapies, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546575342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546575342?lang=zh_cn&edition=full","pubTime":"2025-06-27 01:33","pubTimestamp":1750959210,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日01时33分，Taysha Gene Therapies, Inc.股票出现波动，股价快速下挫5.33%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Vor Biopharma Inc.、Moolec Science Sa C/Wts 、Adial Pharmaceuticals, Inc涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1313.27%、299.94%、219.06%，振幅较大的相关个股有Vor Biopharma Inc.、Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为98.85%、61.67%、46.79%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627013331a71f4088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627013331a71f4088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2546582092","title":"Taysha Gene Therapies, Inc.盘中异动 临近收盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546582092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546582092?lang=zh_cn&edition=full","pubTime":"2025-06-25 04:00","pubTimestamp":1750795230,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日04时00分，Taysha Gene Therapies, Inc.股票出现异动，股价急速下挫5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为1.89%。其相关个股中，内克塔治疗、Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.涨幅较大，Eyenovia, Inc.、Nucana Plc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1439.13%、1051.14%、550.55%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Immatics N V C/Wts 01/07/2025 、内克塔治疗，振幅分别为191.38%、156.58%、116.56%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625040030a71bbb8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625040030a71bbb8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2544178786","title":"Taysha Gene Therapies, Inc.盘中异动 快速下跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544178786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544178786?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:37","pubTimestamp":1750426645,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时37分，Taysha Gene Therapies, Inc.股票出现异动，股价大幅下跌5.45%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062021372597880a51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062021372597880a51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2543637888","title":"Taysha Gene Therapies, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543637888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543637888?lang=zh_cn&edition=full","pubTime":"2025-06-14 03:26","pubTimestamp":1749842815,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日03时26分，Taysha Gene Therapies, Inc.股票出现异动，股价急速下挫5.09%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。消息层面，截至03时26分，《坎托·菲茨杰拉德维持Taysha Gene Therapies买入评级，上调目标价至13美元》资讯为影响Taysha Gene Therapies, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614032655a7081db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614032655a7081db8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2542344951","title":"Taysha Gene Therapies, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542344951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542344951?lang=zh_cn&edition=full","pubTime":"2025-06-11 01:41","pubTimestamp":1749577307,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日01时41分，Taysha Gene Therapies, Inc.股票出现异动，股价快速下挫5.00%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Carisma Therapeutics, Inc.较为活跃，换手率分别为31005.11%、2824.95%、1404.89%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Klotho Neurosciences, Inc.，振幅分别为261.54%、191.40%、114.83%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611014148a4a243e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611014148a4a243e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2541586347","title":"Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541586347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541586347?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:36","pubTimestamp":1749216969,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时36分，Taysha Gene Therapies, Inc.股票出现异动，股价快速拉升5.03%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。该信息摘要如下：Needham：重申Taysha Gene Therapies评级，由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213609a49cfef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213609a49cfef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2540777347","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.21%报2.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540777347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540777347?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:49","pubTimestamp":1748958545,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时49分，Taysha Gene Therapies, Inc.股票出现波动，股价快速上涨5.21%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。该信息摘要如下：Needham：重申Taysha Gene Therapies评级，由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214905a6f8c1cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214905a6f8c1cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2540202797","title":"Needham：重申Taysha Gene Therapies(TSHA.US)评级，由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540202797","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540202797?lang=zh_cn&edition=full","pubTime":"2025-06-03 01:42","pubTimestamp":1748886174,"startTime":"0","endTime":"0","summary":"Needham：重申Taysha Gene Therapies(TSHA.US)评级，由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/03014250813041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TSHA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tayshagtx.com","stockEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":0.185},{"period":"3month","weight":0.506},{"period":"6month","weight":0.7817},{"period":"1year","weight":1.0611},{"period":"ytd","weight":1.9249}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Taysha Gene Therapies, Inc.最初是根据德克萨斯州法律于2019年9月20日成立。该公司于2020年2月13日转换为特拉华州公司。该公司是一家以患者为中心的基因治疗公司，致力于开发和开发商业化基于AAV的基因疗法，用于治疗罕见和大量患者群体的中枢神经系统单基因疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.177294},{"month":2,"riseRate":0.4,"avgChangeRate":0.109391},{"month":3,"riseRate":0.2,"avgChangeRate":-0.123298},{"month":4,"riseRate":0.4,"avgChangeRate":0.009364},{"month":5,"riseRate":0.4,"avgChangeRate":0.055742},{"month":6,"riseRate":0.2,"avgChangeRate":-0.029545},{"month":7,"riseRate":0.6,"avgChangeRate":0.019307},{"month":8,"riseRate":0.8,"avgChangeRate":0.75256},{"month":9,"riseRate":0.2,"avgChangeRate":-0.089587},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.04036},{"month":11,"riseRate":0.5,"avgChangeRate":0.137875},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.0499}],"exchange":"NASDAQ","name":"Taysha Gene Therapies, Inc.","nameEN":"Taysha Gene Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Taysha Gene Therapies, Inc.,TSHA,Taysha Gene Therapies, Inc.股票,Taysha Gene Therapies, Inc.股票老虎,Taysha Gene Therapies, Inc.股票老虎国际,Taysha Gene Therapies, Inc.行情,Taysha Gene Therapies, Inc.股票行情,Taysha Gene Therapies, Inc.股价,Taysha Gene Therapies, Inc.股市,Taysha Gene Therapies, Inc.股票价格,Taysha Gene Therapies, Inc.股票交易,Taysha Gene Therapies, Inc.股票购买,Taysha Gene Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}